People · Operator
Named in public records as an officer, director or promoter · active 2015–2025 · Biotechnology, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Heartflow, Inc. | — | Biotechnology | Series D+ | $391.8M | $2.7B | 2015 |
| Neochord Inc | — | Manufacturing | Series B | $78.2M | $2.4M | 2024 |
| Iantrek, Inc. | — | Biotechnology | Series B | $58.2M | $152.4M | 2025 |
Casey K. Tansey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Casey K. Tansey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Stephen Bloch | 1 | 15 |
| Casey Tansey | 1 | 14 |
| Robert Mitchell | 1 | 9 |
| David Neustaedter | 1 | 7 |
| Dana Mead | 1 | 7 |
| John Stevens | 1 | 6 |
| Marc-Andre Marcotte | 1 | 6 |
| Tsontcho Ianchulev | 1 | 5 |
| John Seaberg | 1 | 5 |
| Steven J. Healy | 1 | 5 |
| James Mazzo | 1 | 4 |
| Timothy I Maudlin | 1 | 4 |
| Mudit K. Jain | 1 | 4 |
| Todd Berg | 1 | 3 |
| Nicole J. Walker | 1 | 3 |
| Michael J. Fulton | 1 | 2 |
| Michael Haydin | 1 | 2 |
| Greg Maurer | 1 | 2 |
| John Zentgraf | 1 | 2 |
| Philip M. Young | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.